Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Replacement therapy with adrenal steroids].

S Hahner1, B Allolio

  • 1Schwerpunkt Endokrinologie und Diabetologie, Medizinische Klinik und Poliklinik I, Universitätsklinikum Würzburg, Josef-Schneider-Strasse 2, 97080, Würzburg, Deutschland. hahner_s@medizin.uni-wuerzburg.de

Der Internist
|April 11, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laparoscopic vs. Robotic transabdominal adrenalectomy- propensity matched analysis and learning curve.

Langenbeck's archives of surgery·2025
Same author

[35/f with gastrointestinal infection and Addison's disease : Preparation for the medical specialist examination: part 28].

Der Internist·2021
Same author

Radiation exposure of adrenal vein sampling: a German Multicenter Study

European journal of endocrinology·2018
Same author

[Adrenal crisis].

Der Internist·2017
Same author

[Addison's disease : Primary adrenal insufficiency].

Der Internist·2016
Same author

Prevalence of Malignancies in Patients With Primary Aldosteronism.

The Journal of clinical endocrinology and metabolism·2016
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Adrenal steroid replacement therapy, including glucocorticoids and dehydroepiandrosterone (DHEA), aims to improve well-being in adrenal insufficiency. Innovations like delayed-release glucocorticoids may enhance treatment, though DHEA is not recommended for anti-aging.

Area of Science:

  • Endocrinology and Metabolism
  • Pharmacology

Context:

  • Adrenal insufficiency necessitates hormone replacement therapy.
  • Current treatments with glucocorticoids, mineralocorticoids, and adrenal androgens offer partial symptom relief.
  • Dehydroepiandrosterone (DHEA) is considered for age-related decline and adrenal insufficiency.

Purpose:

  • To review current adrenal steroid replacement strategies.
  • To explore innovative therapeutic approaches, including novel glucocorticoid formulations.
  • To evaluate the efficacy of DHEA in specific patient populations.

Summary:

  • Adrenal steroid replacement therapy, primarily using glucocorticoids and mineralocorticoids, is standard for adrenal insufficiency.
  • New delayed-release glucocorticoid preparations aim to mimic natural cortisol secretion patterns.

Related Experiment Videos

  • Dehydroepiandrosterone (DHEA) may improve quality of life in adrenal insufficiency but lacks evidence for anti-aging benefits in the elderly.

    • Impact:

    • Improved understanding of adrenal steroid replacement therapy limitations.
    • Potential for enhanced patient well-being with novel glucocorticoid delivery systems.
    • Clarification of DHEA's role, supporting its use in adrenal insufficiency while cautioning against anti-aging applications.